Teladoc Health (NYSE:TDOC) Trading 6.6% Higher – Should You Buy?

Teladoc Health, Inc. (NYSE:TDOC)’s share price was up 6.6% during trading on Wednesday . The stock traded as high as $9.94 and last traded at $10.13. Approximately 696,211 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 3,849,119 shares. The stock had previously closed at $9.50.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on TDOC shares. Evercore ISI raised their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barclays raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 target price (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Finally, TD Cowen decreased their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.08.

Teladoc Health Trading Down 0.8 %

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.73 billion, a PE ratio of -1.74 and a beta of 1.01. The stock’s fifty day simple moving average is $9.99 and its 200 day simple moving average is $9.04.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.95% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Versant Capital Management Inc lifted its stake in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares during the last quarter. Doheny Asset Management CA purchased a new stake in shares of Teladoc Health in the second quarter worth about $46,000. Benjamin F. Edwards & Company Inc. boosted its stake in Teladoc Health by 209.8% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock valued at $49,000 after buying an additional 3,396 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. grew its holdings in Teladoc Health by 194.2% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider’s stock valued at $67,000 after buying an additional 4,549 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.